作者: Olli Carpen , Annika Algars , Minnamaija Lintunen , Jari Sundstrom , Raija Ristamaki
DOI:
关键词: Pathology 、 Cancer 、 Immunohistochemistry 、 EGFR inhibitors 、 Internal medicine 、 Oncology 、 Tissue sections 、 Medicine 、 Cancer cell
摘要: The present invention relates to cancer diagnostics and therapies the detection of alterations in cells that are diagnostic, prognostic or predictive. In particular, provides a method for detecting analyzing whether patient suffering from is responsive treatment with an EGFR inhibitor. method, tissue section sample subjected assays based on immunohistochemistry enzymatic metallography.